4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-050201
Chief Technology Officer sold 20,000 shares at $6.49 ($129,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2023-09-19 | Sale | −20,000 | $6.49 | $129,800 | 7,795,962 | D |
| Open-market sales · 20,000 sh · avg $6.49 · $129,800 | |||||||
Loading xslF345X05/doc4.xml…